Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001276 · ClinicalTrials.gov registry record

Diagnosing and Treating Low Blood Sugar Levels

A clinical trial of Hypoglycemia and Insulinoma, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Recruiting
Registry status
1,500
Enrollment target
1
Study location

NCT00001276 is a study of Hypoglycemia and Insulinoma that is actively recruiting participants, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 1,500 participants, above the 469-participant average among 40 other Hypoglycemia trials with a reported enrollment target (220% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001276, a study of Hypoglycemia and Insulinoma, is actively recruiting participants, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed.

Conditions Studied

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 1991-05-21

What the Registry Record Tells You About NCT00001276

The ClinicalTrials.gov registry entry for NCT00001276 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 469-participant average among 40 other Hypoglycemia trials with a reported enrollment target (220% higher). The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypoglycemia appearing as the primary indexed condition, and to 0 interventions.

NCT00001276 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00001276 about?

NCT00001276 is a clinical study titled "Diagnosing and Treating Low Blood Sugar Levels". Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood suga...

What is the current status of trial NCT00001276?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 1991-05-21.

What conditions does trial NCT00001276 study?

This clinical trial studies the following conditions: Hypoglycemia, Insulinoma.

Who is sponsoring clinical trial NCT00001276?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001276 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoglycemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.